» Articles » PMID: 24458364

Application of Marginal Structural Models in Pharmacoepidemiologic Studies: a Systematic Review

Overview
Publisher Wiley
Date 2014 Jan 25
PMID 24458364
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We systematically reviewed pharmacoepidemiologic studies published in 2012 that used inverse probability weighted (IPW) estimation of marginal structural models (MSM) to estimate the effect from a time-varying treatment.

Methods: Potential studies were retrieved through a citation search within Web of Science and a keyword search within PubMed. Eligibility of retrieved studies was independently assessed by at least two reviewers. One reviewer performed data extraction, and a senior epidemiologist confirmed the extracted information for all eligible studies.

Results: Twenty pharmacoepidemiologic studies were eligible for data extraction. The majority of reviewed studies did not report whether the positivity assumption was checked. Six studies performed intention-to-treat analyses, but none of them reported adherence levels after treatment initiation. Eight studies chose an as-treated analytic strategy, but only one of them reported modeling the multiphase of treatment use. Almost all studies performing as-treated analyses chose the most recent treatment status as the functional form of exposure in the outcome model. Nearly half of the studies reported that the IPW estimate was substantially different from the estimate derived from a standard regression model.

Conclusions: The use of IPW method to control for time-varying confounding is increasing in medical literature. However, reporting of the application of the technique is variable and suboptimal. It may be prudent to develop best practices in reporting complex methods in epidemiologic research.

Citing Articles

Testing the Effectiveness and Cost-Effectiveness of a Combination HIV Prevention Intervention Among Young Cisgender Men Who Have Sex With Men and Transgender Women Who Sell or Exchange Sex in Thailand: Protocol for the Combination Prevention....

Wirtz A, Weir B, Mon S, Sirivongrangson P, Chemnasiri T, Dunne E JMIR Res Protoc. 2020; 9(1):e15354.

PMID: 32012113 PMC: 7011123. DOI: 10.2196/15354.


Multicenter Analysis of Dosing Protocols for Sotalol Initiation.

Biswas M, Levy A, Weber R, Tarakji K, Chung M, Noseworthy P J Cardiovasc Pharmacol Ther. 2019; 25(3):212-218.

PMID: 31707834 PMC: 7113108. DOI: 10.1177/1074248419887710.


Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.

Giral P, Neumann A, Weill A, Coste J Eur Heart J. 2019; 40(43):3516-3525.

PMID: 31362307 PMC: 6855142. DOI: 10.1093/eurheartj/ehz458.


Missing Data in Marginal Structural Models: A Plasmode Simulation Study Comparing Multiple Imputation and Inverse Probability Weighting.

Liu S, Chrysanthopoulou S, Chang Q, Hunnicutt J, Lapane K Med Care. 2019; 57(3):237-243.

PMID: 30664611 PMC: 6436551. DOI: 10.1097/MLR.0000000000001063.


Daring to draw causal claims from non-randomized studies of primary care interventions.

Sourial N, Longo C, Vedel I, Schuster T Fam Pract. 2018; 35(5):639-643.

PMID: 29912314 PMC: 6142715. DOI: 10.1093/fampra/cmy005.


References
1.
Dumas O, Le Moual N, Siroux V, Heederik D, Garcia-Aymerich J, Varraso R . Work related asthma. A causal analysis controlling the healthy worker effect. Occup Environ Med. 2013; 70(9):603-10. DOI: 10.1136/oemed-2013-101362. View

2.
Desai R, Ashton C, Deswal A, Morgan R, Mehta H, Chen H . Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2011; 21(3):233-40. DOI: 10.1002/pds.2175. View

3.
Brumback B, Hernan M, Haneuse S, Robins J . Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Stat Med. 2004; 23(5):749-67. DOI: 10.1002/sim.1657. View

4.
Cole S, Hernan M . Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008; 168(6):656-64. PMC: 2732954. DOI: 10.1093/aje/kwn164. View

5.
Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E . Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis. 2011; 12(1):19-26. PMC: 3266951. DOI: 10.1016/S1473-3099(11)70247-X. View